The World Health Organisation (WHO) has prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, a critical tool for safely administering WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) malaria.
Trending
- Niger gov announces pay raise for health workers
- Fidelity Bank tackles maternal mortality with support for pregnant women
- Environmentalist proffers ways to reduce climate change effects on food security
- Borno gov inaugurates 3 health sector boards, orders comprehensive overhaul
- Kano: Yusuf allocates additional N5bn to settle backlog of pension
- Stress, risk factor for high blood pressure, sudden death – Cardiologist
- EFCC faces scandal as $350,000 and jewellery go missing
- Budget 2025: Tinubu allocates N2.3bn in entitlements to former leaders [BREAKDOWN]
